Abstract
By uncovering complex dynamics in the expression or localization of transcriptional regulators in single cells that were otherwise hidden at the population level, live cell imaging has transformed our understanding of how cells sense and orchestrate appropriate responses to changes in their internal state or extracellular environment. This has proved particularly true for the nuclear factor-kappaB (NF-κB) family of transcription factors, key regulators of the inflammatory response and innate immune function, which are capable of encoding information about the mode and intensity of stimuli in the dynamics of NF-κB nuclear accumulation and loss. While live cell imaging continues to serve as a useful tool in ongoing efforts to characterize the feedbacks that shape these dynamics and to connect dynamics to downstream gene expression, it is also proving invaluable for recent studies that seek to determine how intracellular pathogens subvert NF-κB signaling to survive and replicate within host cells by providing quantitative information about the pathogen and changes in NF-κB activity during different stages of an infection. Here, we provide a brief overview of NF-κB signaling in innate immune cells and review recent literature that uses live imaging to investigate the mechanisms by which bacterial and yeast pathogens modulate NF-κB in a variety of different host cell types to evade destruction or maintain the viability of an intracellular growth niche.
Keywords: NF-κB, dynamics, live cell imaging, macrophage, host:pathogen interactions, innate immunity
Introduction
The nuclear factor-kappa B (NF-κB) pathway is considered a master regulator of inflammation and is intimately involved in the cellular response to infection (1). Similar to other mammalian transcription factor pathways, such as p53 (2–4), and NFAT (5), the NF-κB pathway can exhibit distinct dynamic responses to different stimuli (6–9). These dynamics, which include damped oscillations (7), allow cells to encode complex information about the modality, concentration, and duration of a particular stimulus in the amplitude, frequency, and persistence of oscillations (6, 10, 11). These dynamics are essentially decoded at the level of gene expression with different patterns of behavior leading to differing cell fates and phenotypes (10, 12, 13). This phenomenon, which is often referred to as dynamic multiplexing, allows cells to efficiently use a limited number of signaling pathways to deal with highly complex signaling environments (11). The dynamic behavior of the NF-κB pathway can be challenging to study using standard biochemical techniques that use population averaging because the responses of individual cells to a given stimulus can differ markedly (7, 9). This may be due to the difficult to control effects of paracrine and autocrine signaling (12), inherent differences between cells and the signaling history of the cell (extrinsic noise), and the stochasticity of certain elements of the signaling pathway (e.g., transcription and translation; intrinsic noise) (8, 14, 15). For these reasons, live cell imaging (often in combination with mathematical modeling) has become an invaluable tool for studying NF-κB signaling (16, 17), and has been used to characterize the specific feedbacks that shape the behavior of the pathway (6, 7, 18, 19). For similar reasons, live cell imaging is being increasingly used to improve our understanding of the role NF-κB signaling plays during infection with intracellular pathogens (20–23). In tissue culture models of infection, only a fraction of the cells within the population may become infected and this will occur at different times between cells making it difficult to build an accurate picture of how NF-κB signaling is affected during each stage of the pathogenic process. Live cell imaging provides a means to deconvolve events occurring during different stages of an infection (20), distinguish between non-infected and infected cells (23), as well as keeping track of changes in intracellular microbial burden within individual cells (22).
In the following review, we will provide a brief overview of NF-κB signaling and describe how live cell microscopy has been used to investigate the capacity of the pathway to encode information about the signaling environment of the cell in the dynamics of NF-κB transcription factors. We will discuss the duality of NF-κB signaling within the context of host:pathogen interactions and how it can both aid and hinder the response to an infection. Finally, we describe how recent live cell studies have provided new insights into the ways in which different microbial pathogens incorporate NF-κB modulation as a part of intracellular survival strategies.
Basic Insights Into NF-κB Regulation From Live Cell Imaging
At the core of the NF-κB pathway are the Rel family of transcription factors: p65 (RelA), RelB, c-Rel, p100/p50, and p105/p52, each containing a central DNA binding motif, known as the Rel homology domain (24). These proteins can form homo- or heterodimers in virtually any combination with p65:p50 dimers appearing to be the most common. In the absence of stimulus, NF-κB activity is suppressed by inhibitor kappaB (IκB) proteins, which anchor NF-κB transcription factors in the cytoplasm. The canonical wing of the NF-κB pathway, defined by the activity of p65-containing dimers, can be activated by diverse stimuli. These range from the proinflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin-1 beta (IL-1β), to microbe-associated molecular patterns (MAMPs) like lipopolysaccharide (LPS) and flagellin, which are recognized by surface or phagosomal pattern recognition receptors (PRRs), including the toll-like receptors (TLRs) (25). In each case, activation proceeds via the IκB kinase (IKK) complex, a convergence point for the NF-κB pathway. The IKK complex phosphorylates both NF-κB and IκB proteins (26, 27), regulating the activity of the former and stimulating the degradation of the latter. In the case of IκBα, an IκB isoform associated with the regulation of canonical NF-κB signaling, the protein is phosphorylated at serine 32 and 36, creating a phospho-degron, which is recognized by the E3 ubiquitin ligase complex, SCFβ−TRCP, and leads to polyubiquitination and proteasomal degradation of IκBα (28). IKK-dependent phosphorylation also promotes the degradation of other IκB isoforms (i.e., IκBβ and ε) and the processing of p100 and p105 to p52, and p50, respectively [reviewed in 29).
In addition to regulating genes involved in innate immunity and inflammation, p65 also promotes the expression of a core set of negative regulators, IκBα, IκBε, and tumor necrosis factor alpha-induced protein 3 (TNFAIP3/A20, Figure 1) (6, 7, 19). The inherent delay in the expression of these proteins is thought to be responsible for the oscillatory behavior of the pathway. While each of these feedbacks was first identified in genetic and biochemical studies (19, 30–33), the individual roles played by these in shaping NF-κB dynamics was clarified by subsequent studies using live imaging and mathematical modeling. As RNA polymerase II associates with the IκBα promoter prior to stimulation (6), this feedback is rapidly activated on nuclear translocation of p65 and is perhaps most closely linked to the oscillatory behavior of the pathway (7). Expression of IκBε is delayed relative to IκBα and this may play a role in increasing the heterogeneity of the response between cells in addition to helping terminate NF-κB activation after transient stimulation (6, 19). Finally, A20 provides a non-redundant feedback that operates over longer timescales (34), inhibiting IKK activity by antagonizing upstream regulators (35). Expression of the TNFAIP3 gene, which encodes A20, is temperature sensitive and may imbue the NF-κB pathway with the ability to adjust the expression of select NF-κB-regulated genes across physiologically relevant temperatures during infection and inflammation (36).
The core negative feedbacks are supplemented by additional cell type and stimulus-specific feedbacks. The best example of this is the feedback dominance switching observed in macrophages exposed to LPS (18), which enables cells to discriminate between high and low LPS concentrations. In response to high concentrations of LPS, p65 is able to transactivate expression of the Rela gene, increasing the expression of p65 and overcoming negative feedbacks that would otherwise curtail NF-κB activity. This mechanism is likely specific to macrophages or at least lymphoid cells as it requires expression of Ikaros, a transcription factor involved in lymphoid development (37). The NF-κB-regulated expression of TNFα could also be considered a second positive feedback, acting as an autocrine or paracrine signal to prolonging the NF-κB response to LPS in mouse embryonic fibroblasts as well as increasing the heterogeneity of the response in murine macrophages (12, 38).
The challenging task of assigning meaning to NF-κB dynamics has been addressed by recent studies that supplement live cell imaging with microfluidics and transcriptional profiling to either shape and synchronize NF-κB dynamics across a cell population through periodic forcing (10) or link the dynamics in individual cells to single cell RNAseq transcriptional profiles (12). These studies, together with earlier work (6), collectively show that different dynamic responses can produce distinct patterns of gene expression and changes in cellular function. This appears to be because the transcripts of NF-κB target genes with related functions are expressed with similar kinetics or have similar stabilities. In this way, the expression of cytokines and cytokine receptors closely track NF-κB dynamics and will even oscillate, whereas the transcripts for target genes associated with other processes, including remodeling the extracellular matrix, accumulate more slowly and require repeated cycles of NF-κB nuclear accumulation in order to be expressed at biologically meaningful concentrations (10). Therefore, it seems logical that exogenous factors that influence NF-κB dynamics could effectively alter their meaning, impacting gene expression, and potentially compromising the response.
A large number of microbial pathogens are known to utilize effectors that directly target components of the NF-κB system and those that replicate or survive within host cells may also indirectly affect NF-κB as a consequence of other pathogen-encoded activities (39, 40). In most studies, these effects are characterized as simply inhibiting or activating NF-κB signaling in host cells. Given our current understanding of the relationship between NF-κB dynamics and gene expression, we assert that a more nuanced view of these effects is called for if we are to fully understand the role NF-κB signaling plays in innate immunity and host: pathogen interactions.
Live Imaging as a Tool to Study NF-κB Modulation by Intracellular Pathogens
Overall, the use of live cell imaging to investigate NF-κB responses in cells exposed to live pathogens is surprisingly uncommon and is dwarfed by a wealth of similar studies using purified microbial ligands. Perhaps for this reason, the earliest publications in this area compared the kinetics of the TLR4-NF-κB response in cells co-cultured with intact, extracellular E. coli or LPS isolated from the same organism, showing similar effects (41). Other early publications used live cell imaging to correlate the attachment of bacteria to the surface of host cells with the timing of an NF-κB nuclear accumulation and disentangle the asynchronous responses between cells. This was used in two separate studies by the Meyer group to show that H. pylori with an intact type IV secretion system could induce p65 oscillations in human gastric epithelial cells (42), and that the force of type IV pilus retraction could stimulate waves of p65 nuclear translocation as Neisseria gonorrhoeae microcolonys form and fuse on the surface of infected cells (21).
While these studies using extracellular pathogens have been informative, they are mainly descriptive and do not provide deeper insights into how NF-κB signaling alters during the course of an infection or how it impacts outcome. During intracellular infections, NF-κB activity is very much a double-edged sword that can benefit both host and pathogen. It can strengthen the innate immune response of the host through expression of pro-inflammatory cytokines and directly enhance the microbicidal activity of macrophages by promoting expression of Nos2 and other markers of M1 polarization (43–45). However, by positively regulating the expression of anti-apoptotic proteins, prolonged NF-κB activation can extend the survival of infected cells, providing a niche for the intracellular persistence and replication of the pathogen. Perhaps for these reasons, a wide variety of bacterial and eukaryotic pathogens, including Salmonella (23, 46, 47), Legionella pneumophilia (20, 48), and Toxoplasma gondii (49, 50) target NF-κB during infection. It is also common for individual pathogens to express multiple effectors, regulating different components of the NF-κB system to contrasting effect, deploying them individually or in combinations at different stages of an infection (39).
Delineating the various events that impact NF-κB activity during intracellular infection can be especially challenging. Intracellular pathogenesis is a multistage process, involving the microbe-active or -passive entry into host cells, intracellular survival of the pathogen, which may be accompanied by replication, and eventual exit (51). Changes in NF-κB activity may be associated with any phase of the process, driven by recognition of microbial antigens by host cell PRRs, either pre- or post-entry, or through the delivery of microbial effectors into the host cell. Even in cell culture models of infection, these events will happen asynchronously and, indeed, intracellular microbial burden will vary between cells. Furthermore, non-infected cells may exhibit so-called bystander effects, either through interaction with shed MAMPs, paracrine signaling, or a combination of both, complicating analysis (23). However, as many intracellular pathogens can be genetically modified to express fluorescent markers or are large enough to be identified in brightfield images, live cell microscopy can be used to track the progress of infection in individual cells while simultaneously monitoring changes in the localization of NF-κB proteins (Figures 2A,B) (22, 23). Quantitative time-resolved measurements of this type, and the ability to separate the responses of bystanders from those occurring in infected cells would be impractical (if not impossible) to achieve using bulk cell analysis techniques.
This approach was used in a recent study by Ramos-Marquès et al. to characterize the effect of Salmonella enterica serovar Typhimurium (S. Typhimurium) on NF-κB signaling in fibroblasts (23). S. Typhimurium is a cause of inflammatory enteric disorders in mammals and is able to colonize fibroblasts after penetrating gut epithelium (52). While it was known that exposure to S. Typhimurium was capable of triggering NF-κB activity in these cells through recognition of shed MAMPs, LPS and flagellin by TLR4 and TLR5, respectively, it was previously unclear whether intracellular persistence of the bacterium affected the response. In order to explore this, the investigators used live imaging together with microfluidics in order to transiently expose fibroblasts to live bacteria for 10 min. This approach both limited the exposure of non-infected cells to shed extracellular MAMPs while also minimizing the effects of paracrine signaling. Although infected cells exhibited a heightened initial NF-κB response to S. Typhimurium exposure, presumably due to engagement of both surface and intracellular TLRs, subsequent exposure to bacteria or TNFα elicited a much-diminished response. The decreased nuclear translocation of p65 in these cells was accompanied by decreased IL1B and increased SOCS3 expression, a cytokine signaling suppressor. These effects required a functional type III secretion system expressed from the Salmonella pathogenicity island 1 (T1) but not pathogenicity island 2 (T2). While the specific S. Typhimurium effectors responsible were not identified, it is known that a variety of T1 and T2 effectors directly target NF-κB pathway components and are capable of both increasing and decreasing NF-κB activity in different cellular contexts (47, 53, 54). These include AvrA, which inhibits p65 nuclear translocation by deubiquitinating IκBα (47). The ability to selectively employ combinations of these effectors in different host cell types may provide S. Typhimurium with the capability to tune host NF-κB responses to contrasting effect, either leading to the apoptosis of the host cell or extending its viability for use as a growth niche.
Translational Interference: A Receptor-Independent Mechanism of Altering NF-κB Signaling in Host Cells
Facultative intracellular pathogens, by definition, do not require a mammalian host for replication. It is thought, therefore, that many of the strategies employed by these pathogens to evade host macrophages evolved in order to survive interactions with environmental protozoa, such as amoeba (55). These strategies may involve the expression of virulence factors that enable pathogens to either avoid ingestion by phagocytes or by targeting highly conserved, essential eukaryotic processes within the host cell in order to survive ingestion. It is notable then that a variety of bacterial and eukaryotic intracellular pathogens are able to induce translational interference, the partial suppression of nascent protein synthesis in host cells [reviewed in 56). While the primary purpose of this might be simply to increase the availability of free amino acids within the intracellular environment for microbial growth and attenuate innate immune function, its effects on cellular signaling should not necessarily be dismissed as “collateral” or a secondary effect. As feedback in the NF-κB system requires protein synthesis, translational interference will alter NF-κB dynamics and downstream gene expression. This has been illustrated by experiments where partial inhibition of ribosome function in the absence of external stimulus or microbial pathogens have driven a rapid reduction in IκBα (and slower loss of IκBβ and IκBε) and nuclear accumulation of p65 in murine fibroblasts (57). Within the context of an intracellular infection, this could hypothetically aid the pathogen by disrupting the normal operation of the pathway but it may also provide a receptor-independent mechanism by which intracellular microbial activity could be detected and responded to by host cells. These possibilities have been explored in a number of recent studies utilizing live cell imaging to measure NF-κB activity during infection with the facultative intracellular pathogens, L. pneumophilia and Cryptococcus neoformans (20, 22).
The encapsulated fungal pathogen, C. neoformans, is ubiquitous in urban environments and infects most individuals during childhood. It rarely causes disease in immune-competent hosts (58). Instead, it can enter a chronic, dormant state in host macrophages, often for many years, before later emerging should the immune system become compromised, leading to pneumonia and meningitis. As such, it is generally characterized as an AIDS-associated infection and is thought to be responsible for approximately 181,000 deaths per year worldwide, with most occurring in sub-Saharan Africa where HIV is endemic (59).
The C. neoformans polysaccharide capsule is essential for virulence and is largely made up of glucuronoxylomannan (GXM). GXM is synthesized and deployed as capsule rapidly after the inhalation of C. neoformans spores, increasing the effective radius of the yeast particle, impeding ingestion by host phagocytes and masking cell wall antigens that could be detected by PRRs. GXM is continually shed during growth as polysaccharide-filled vesicles both pre- and post-phagocytosis and appears to have immunomodulatory activities in this form (60). While there is disagreement in the literature about the precise effects of free GXM (61), possibly due to differences in the cell models used and GXM purification methods, several groups have shown that it is capable of suppressing TLR4 and MyD88-dependent NF-κB activation in a FcγRIIb and SHIP-dependent manner both in vitro and in a murine model of endotoxic shock (22, 62, 63).
Interestingly, the effects of GXM and capsular polysaccharides on NF-κB signaling may differ when secreted by phagosomal C. neoformans. This was explored in a recent study by Hayes et al. (22), which utilized the RAW264.7 NF-κB reporter cell line first described by Sung et al. (18), in order to simultaneously monitor p65 localization, the expression of an mCherry reporter of TNF promoter transactivation, and intracellular microbial burden. During these experiments, microbial burden was highly variable, as C. neoformans is able to both replicate within the acidified environment of the phagolysosome and also exit host cells without inducing cell death by non-lytic extrusion (Figure 2A) (64). While phagocytosis of encapsulated C. neoformans alone did not have an immediate effect on NF-κB signaling in host macrophages, it was capable of influencing the response of infected cells to pro-inflammatory stimulus. Specifically, when infected cells were challenged with LPS, the amplitude and duration of the response was increased and this was found to be dose-dependent, escalating with intracellular microbial burden (Figures 2B,C). This effect was lost when macrophages were infected with the capsule-deficient, GXM-negative C. neoformans mutant strain, CAP59, indicating that this effect was GXM-dependent. Interestingly, only live GXM-positive C. neoformans strains but not CAP59 or heat killed yeast induced a measurable decrease in nascent protein production in host cells, as measured by ribopuromycylation, suggesting that the altered NF-κB response was a product of GXM-induced translational interference. These data were consistent with the findings of an earlier independent study showing a reduction in protein translation rate in C. neoformans-infected J774.1 murine macrophage-like cells (65). Even though the overall change in NF-κB dynamics in the live cell imaging study were slight and would be difficult to detect in biochemical assays, it seems likely that it would be sufficient to influence the pattern of NF-κB regulated gene expression given the strong association between NF-κB dynamics and transcriptional output, which has been clearly demonstrated in macrophages (12).
The strategies employed by intracellular pathogens to subvert signaling may differ by cell type and can also alter as an infection progresses. For example, L. pneumophila, the causative agent of Legionnaires' disease can directly activate IκBα degradation and NF-κB in host macrophages through secretion of LegK1 effector proteins, an IKK mimic (48), promoting host cell survival. However, in epithelial cells, L. pneumophila induces biphasic NF-κB activation, which was resolved in a live cell imaging study by the Meyer group (20). The first phase of activation involves the recognition of flagellin, a component of L. pneumophila flagella, by TLR5, triggering transient MyD88-dependent nuclear translocation of p65 in infected cells (Figure 2D). This was associated with NF-κB-dependent expression of IL-8, likely benefiting the host (66, 67). The second phase was TLR5 and MyD88-independent and instead required a functional Dot/lcm type IV secretion system, used by the bacterium to deliver effector proteins into host cells from the Legionella-containing vacuole (Figure 2E). This stimulated long-lasting, non-oscillatory p65 nuclear localization and was associated with a reduction in IκBα levels and expression of the anti-apoptotic proteins cIAP1, cFLIP, and XIAP, which the authors hypothesized would aid the pathogenesis of L. pneumophila through preservation of the intracellular growth niche. It is notable that earlier studies interpreted the TLR5-dependent and Dot/lcm-dependent responses as separate effects achieved at different multiplicities of infection rather than sequential events occurring during infection (68, 69). In this regard, the use of live cell imaging was instrumental in correcting this misconception.
Subsequent studies by an independent group indicate that the second phase of NF-κB activation in L. pneumophila infected cells is a product of translation interference (40), requiring the L. pneumophila Dot/Icm type IV secretion system to deliver a cocktail of five bacterial effectors into host cells to globally decrease—but not completely inhibit—mRNA translation. As IκBα proteins are particularly labile and turn over quickly, under these conditions, the rate of IκBα degradation exceed the rate of production, resulting in a rapid decrease in IκBα protein levels accompanied by stable nuclear accumulation of NF-κB in host cells. This results in the selective “superinduction” of specific transcripts that are not normally responsive to transient PRR-mediated NF-κB activity. While the precise mechanism remains unclear it seems likely that the shear number of these transcripts and possibly the stability of the protein products overcome the translational bottleneck in L. pneumophila infected cells. Proteins upregulated in these cells included the proinflammatory cytokines, interleukin-23 and GM-CSF, suggesting that this stable nuclear localization of p65 may not be entirely beneficial to the pathogen and may represent a receptor-independent mechanism of NF-κB activation, providing a means to initiate an innate immune response.
Concluding Remarks
Live cell imaging has transformed our understanding of how the NF-κB system coordinates the cellular response to stimuli, especially in innate immune cells. The ability of this technique to disentangle differing and asynchronous responses of individual cells has also made it ideal for investigating how intracellular pathogens manipulate NF-κB signaling in host cells, particularly in instances where the effects on this pathway are influenced by intracellular microbial burden or the changing repertoire of microbial ligands and effectors presented or deployed during the course of an infection (22). Despite the various advantages of the technique, to the author's knowledge, it has seldom been used for this purpose and this mini-review represents a relatively complete overview of the current literature in this area.
Prior genetic and biochemical studies have shown that modulation of host cell NF-κB signaling is relatively common among gastrointestinal pathogens, including Helicobactor pylori (70), Shigella (71), and Yesinia (72), and has been demonstrated in other invasive bacteria, such as Mycobacterium tuberculosis (73). Overall, it appears that NF-κB modulation is utilized by pathogens to either “buy-time” for intracellular replication, as employed by Mycobacterium tuberculosis and Shigella (71, 73) by stimulating the expression of pro-survival NF-κB-responsive genes, or to do quite the reverse, by using effectors that inhibit host cell NF-κB-activity to blunt an inflammatory response or promote apoptosis in order to evade destruction by innate immune cells or aid escape and dissemination (72). While these previous studies have successfully identified the molecular players required for subversion of NF-κB signaling in host cells, a reexamination of these effects using live cell imaging is merited. As demonstrated by the research highlighted in this review, this method could help to resolve otherwise hidden bi- or multiphasic responses to intracellular pathogens (20), and perhaps most interestingly, link the different NF-κB responses of individual cells to specific transcriptional responses using fluorescent reporters (18, 22) or downstream single cell transcriptomics (12) and different infection outcomes (e.g., intracellular replication, non-lytic exocytosis, host cell death, killing of the pathogen etc.).
Despite the potentially very useful insights that can be obtained through the application of this technique, our enthusiasm should be tempered by an awareness of its inherent limitations, which stem from the absolute requirement to modify the system being studied through the use of fluorescent tags and the over-expression of exogenous proteins, both of which have the potential to affect the behavior of the pathway. The former is perhaps least concerning as careful characterization of p65 fluorescent fusions has suggested that GFP-tags neither interfere with the ability of the protein to transactivate gene transcription or correctly associate with regulators, including the IκB proteins (74), although it may have as yet unrecognized consequences. The effects of protein overexpression on the behavior of the NF-κB are less clear-cut. Experimental evidence has suggested that p65 overexpression has little effect on pathway behavior (75), although separate studies have indicated IκBα levels recover more rapidly after stimulation in cells expressing p65-GFP in addition to the endogenous protein (42). More recent studies have attempted to minimize the effects of overexpression by using BACS or stable transduction of viral constructs to express p65 fusions under the control of the endogenous promoter (18, 36). In these ways, expression levels of tagged p65 can be regulated appropriately by the cell and kept more closely to endogenous levels than might be achieved through transient transfection of plasmid constructs. It also seems likely that future studies will utilize CRISPR/Cas9-based gene editing to introduce fluorescent proteins into the endogenous locus of NF-κB genes to avoid protein overexpression.
Author Contributions
The manuscript was designed by DN and written by DN with assistance from RN. All authors read and approved the final manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The authors would like to acknowledge members of the DEN lab and Dr. Erin E. McClelland (Middle Tennessee State University) for useful discussions.
Footnotes
Funding. This work was supported by funds from the National Institutes of Health (NIAID 1R15AI135826-01) and the Molecular Biosciences (MOBI) doctoral program at Middle Tennessee State University (MTSU) to DN.
References
- 1.Zhang Q, Lenardo MJ, Baltimore D. 30 years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell (2017) 168:37–57. 10.1016/j.cell.2016.12.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, Lahav G. p53 dynamics control cell fate. Science (2012) 336:1440–4. 10.1126/science.1218351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Batchelor E, Loewer A, Mock C, Lahav G. Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol. (2011) 7:488. 10.1038/msb.2011.20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell (2008) 30:277–89. 10.1016/j.molcel.2008.03.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yissachar N, Sharar Fischler T, Cohen AA, Reich-Zeliger S, Russ D, Shifrut E, et al. Dynamic response diversity of NFAT isoforms in individual living cells. Mol Cell (2013) 49:322–30. 10.1016/j.molcel.2012.11.003 [DOI] [PubMed] [Google Scholar]
- 6.Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, Sillitoe K, et al. Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science (2009) 324:242–6. 10.1126/science.1164860 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science (2004) 306:704–8. 10.1126/science.1099962 [DOI] [PubMed] [Google Scholar]
- 8.Werner SL, Barken D, Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science (2005) 309:1857–61. 10.1126/science.1113319 [DOI] [PubMed] [Google Scholar]
- 9.Kellogg RA, Tian C, Etzrodt M, Tay S. Cellular decision making by non-integrative processing of TLR inputs. Cell Rep. (2017) 19:125–35. 10.1016/j.celrep.2017.03.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zambrano S, De Toma I, Piffer A, Bianchi ME, Agresti A. NF-kappaB oscillations translate into functionally related patterns of gene expression. Elife (2016) 5:e09100. 10.7554/eLife.09100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Levine JH, Lin Y, Elowitz MB. Functional roles of pulsing in genetic circuits. Science (2013) 342:1193–200. 10.1126/science.1239999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lane K, Van Valen D, DeFelice MM, Macklin DN, Kudo T, Jaimovich A, et al. Measuring signaling and RNA-seq in the same cell links gene expression to dynamic patterns of NF-kappaB activation. Cell Syst. (2017) 4:458–69.e455. 10.1016/j.cels.2017.03.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Inoue K, Shinohara H, Behar M, Yumoto N, Tanaka G, Hoffmann A, et al. Oscillation dynamics underlie functional switching of NF-kappaB for B-cell activation. NPJ Syst Biol Appl. (2016) 2:16024. 10.1038/npjsba.2016.24 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tay S, Hughey JJ, Lee TK, Lipniacki T, Quake SR, Covert MW. Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature (2010) 466:267–71. 10.1038/nature09145 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kellogg RA, Tay S. Noise facilitates transcriptional control under dynamic inputs. Cell (2015) 160:381–92. 10.1016/j.cell.2015.01.013 [DOI] [PubMed] [Google Scholar]
- 16.Basak S, Behar M, Hoffmann A. Lessons from mathematically modeling the NF-kappaB pathway. Immunol Rev. (2012) 246:221–38. 10.1111/j.1600-065X.2011.01092.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sung MH, McNally JG. Live cell imaging and systems biology. Wiley Interdiscip Rev Syst Biol Med. (2011) 3:167–82. 10.1002/wsbm.108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sung MH, Li N, Lao Q, Gottschalk RA, Hager GL, Fraser ID. Switching of the relative dominance between feedback mechanisms in lipopolysaccharide-induced NF-kappaB signaling. Sci Signal. (2014) 7:ra6. 10.1126/scisignal.2004764 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kearns JD, Basak S, Werner SL, Huang CS, Hoffmann A. IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol. (2006) 173:659–64. 10.1083/jcb.200510155 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bartfeld S, Engels C, Bauer B, Aurass P, Flieger A, Brüggemann H, et al. Temporal resolution of two-tracked NF-kappaB activation by Legionella pneumophila. Cell Microbiol. (2009) 11:1638–51. 10.1111/j.1462-5822.2009.01354.x [DOI] [PubMed] [Google Scholar]
- 21.Dietrich M, Bartfeld S, Munke R, Lange C, Ogilvie LA, Friedrich A, et al. Activation of NF-kappaB by Neisseria gonorrhoeae is associated with microcolony formation and type IV pilus retraction. Cell Microbiol. (2011) 13:1168–82. 10.1111/j.1462-5822.2011.01607.x [DOI] [PubMed] [Google Scholar]
- 22.Hayes JB, Sircy LM, Heusinkveld LE, Ding W, Leander RN, McClelland EE, et al. Modulation of macrophage inflammatory nuclear factor kappaB (NF-kappaB) signaling by intracellular Cryptococcus neoformans. J Biol Chem. (2016) 291:15614–27. 10.1074/jbc.M116.738187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ramos-Marquès E, Zambrano S, Tiérrez A, Bianchi ME, Agresti A, García-Del Portillo F. Single-cell analyses reveal an attenuated NF-kappaB response in the Salmonella-infected fibroblast. Virulence (2017) 8:719–40. 10.1080/21505594.2016.1229727 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev. (2006) 210:171–86. 10.1111/j.0105-2896.2006.00375.x [DOI] [PubMed] [Google Scholar]
- 25.Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. (2007) 13:460–9. 10.1016/j.molmed.2007.09.002 [DOI] [PubMed] [Google Scholar]
- 26.DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature (1997) 388:548–54. 10.1038/41493 [DOI] [PubMed] [Google Scholar]
- 27.Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem. (1999) 274:30353–6. 10.1074/jbc.274.43.30353 [DOI] [PubMed] [Google Scholar]
- 28.Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. (1995) 14:2876–83. 10.1002/j.1460-2075.1995.tb07287.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kanarek N, London N, Schueler-Furman O, Ben-Neriah Y. Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harb Perspect Biol. (2010) 2:a000166. 10.1101/cshperspect.a000166 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA. (1993) 90:2532–6. 10.1073/pnas.90.6.2532 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Scott ML, Fujita T, Liou HC, Nolan GP, Baltimore D. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. (1993) 7:1266–76. 10.1101/gad.7.7a.1266 [DOI] [PubMed] [Google Scholar]
- 32.Sun SC, Ganchi PA, Ballard DW, Greene WC. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science (1993) 259:1912–5. 10.1126/science.8096091 [DOI] [PubMed] [Google Scholar]
- 33.Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA. (1996) 93:6721–5. 10.1073/pnas.93.13.6721 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Werner SL, Kearns JD, Zadorozhnaya V, Lynch C, O'Dea E, Boldin MP, et al. Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev. (2008) 22:2093–101. 10.1101/gad.1680708 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Shembade N, Ma A, Harhaj EW. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science (2010) 327:1135–9. 10.1126/science.1182364 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Harper CV, Woodcock DJ, Lam C, Garcia-Albornoz M, Adamson A, Ashall L, et al. Temperature regulates NF-kappaB dynamics and function through timing of A20 transcription. Proc Natl Acad Sci USA. (2018) 115:E5243–9. 10.1073/pnas.1803609115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Georgopoulos K. Transcription factors required for lymphoid lineage commitment. Curr Opin Immunol. (1997) 9:222–7. 10.1016/S0952-7915(97)80139-2 [DOI] [PubMed] [Google Scholar]
- 38.Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science (2005) 309:1854–7. 10.1126/science.1112304 [DOI] [PubMed] [Google Scholar]
- 39.Rahman MM, McFadden G. Modulation of NF-kappaB signalling by microbial pathogens. Nat Rev Microbiol. (2011) 9:291–306. 10.1038/nrmicro2539 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fontana MF, Banga S, Barry KC, Shen X, Tan Y, Luo ZQ, et al. Secreted bacterial effectors that inhibit host protein synthesis are critical for induction of the innate immune response to virulent Legionella pneumophila. PLoS Pathog. (2011) 7:e1001289. 10.1371/journal.ppat.1001289 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.James CD, Moorman MW, Carson BD, Branda CS, Lantz JW, Manginell RP, et al. Nuclear translocation kinetics of NF-kappaB in macrophages challenged with pathogens in a microfluidic platform. Biomed Microdevices (2009) 11:693–700. 10.1007/s10544-008-9281-5 [DOI] [PubMed] [Google Scholar]
- 42.Bartfeld S, Hess S, Bauer B, Machuy N, Ogilvie LA, Schuchhardt J, et al. High-throughput and single-cell imaging of NF-kappaB oscillations using monoclonal cell lines. BMC Cell Biol. (2010) 11:21. 10.1186/1471-2121-11-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Nat Acad Sci USA. (1993) 90:9730–4. 10.1073/pnas.90.20.9730 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. (1994) 269:4705–8. [PubMed] [Google Scholar]
- 45.Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol. (2007) 8:1. 10.1186/1471-2172-8-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Le Negrate G, Faustin B, Welsh K, Loeffler M, Krajewska M, Hasegawa P, et al. Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol. (2008) 180:5045–56. 10.4049/jimmunol.180.7.5045 [DOI] [PubMed] [Google Scholar]
- 47.Ye Z, Petrof EO, Boone D, Claud EC, Sun J. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol. (2007) 171:882–92. 10.2353/ajpath.2007.070220 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ge J, Xu H, Li T, Zhou Y, Zhang Z, Li S, et al. A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Proc Nat Acad Sci USA. (2009) 106:13725–30. 10.1073/pnas.0907200106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Molestina RE, Sinai AP. Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha. Cell Microbiol. (2005) 7:351–62. 10.1111/j.1462-5822.2004.00463.x [DOI] [PubMed] [Google Scholar]
- 50.Molestina RE, Sinai AP. Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection. J Cell Sci. (2005) 118:5785–96. 10.1242/jcs.02709 [DOI] [PubMed] [Google Scholar]
- 51.Casadevall A. Evolution of intracellular pathogens. Annu Rev Microbiol. (2008) 62:19–33. 10.1146/annurev.micro.61.080706.093305 [DOI] [PubMed] [Google Scholar]
- 52.Aiastui A, Pucciarelli MG, García-del Portillo F. Salmonella enterica serovar typhimurium invades fibroblasts by multiple routes differing from the entry into epithelial cells. Infect Immun. (2010) 78:2700–13. 10.1128/IAI.01389-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Haraga A, Miller SI. A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun. (2003) 71:4052–8. 10.1128/IAI.71.7.4052-4058.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Keestra AM, Winter MG, Auburger JJ, Frässle SP, Xavier MN, Winter SE, et al. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature (2013) 496:233–7. 10.1038/nature12025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA. (2001) 98:15245–50. 10.1073/pnas.261418798 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Mohr I, Sonenberg N. Host translation at the nexus of infection and immunity. Cell Host Microbe (2012) 12:470–83. 10.1016/j.chom.2012.09.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.O'Dea EL, Barken D, Peralta RQ, Tran KT, Werner SL, Kearns JD, et al. A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol. (2007) 3:111. 10.1038/msb4100148 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski La, Niang R, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics (2001) 107:E66. 10.1542/peds.107.5.e66 [DOI] [PubMed] [Google Scholar]
- 59.Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. (2017) 17:873–81. 10.1016/S1473-3099(17)30243-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Nat Acad Sci USA. (2002) 99:3165–70. 10.1073/pnas.052702799 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol. (2001) 166:4620–6. 10.4049/jimmunol.166.7.4620 [DOI] [PubMed] [Google Scholar]
- 62.Monari C, Bistoni F, Casadevall A, Pericolini E, Pietrella D, Kozel TR, et al. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J Infect Dis. (2005) 191:127–37. 10.1086/426511 [DOI] [PubMed] [Google Scholar]
- 63.Monari C, Kozel TR, Paganelli F, Pericolini E, Perito S, Bistoni F, et al. Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor. J Immunol. (2006) 177:6842–51. 10.4049/jimmunol.177.10.6842 [DOI] [PubMed] [Google Scholar]
- 64.Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol. (2006) 16:2161–5. 10.1016/j.cub.2006.09.061 [DOI] [PubMed] [Google Scholar]
- 65.Coelho C, Souza AC, Derengowski Lda S, de Leon-Rodriguez C, Wang B, Leon-Rivera R, et al. Macrophage Mitochondrial and stress response to ingestion of Cryptococcus neoformans. J Immunol. (2015) 194:2345–57. 10.4049/jimmunol.1402350 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Schmeck B, N'Guessan PD, Ollomang M, Lorenz J, Zahlten J, Opitz B, et al. Legionella pneumophila-induced NF-kappaB- and MAPK-dependent cytokine release by lung epithelial cells. Eur Respir J. (2007) 29:25–33. 10.1183/09031936.00141005 [DOI] [PubMed] [Google Scholar]
- 67.Teruya H, Higa F, Akamine M, Ishikawa C, Okudaira T, Tomimori K, et al. Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells. BMC Microbiol. (2007) 7:102. 10.1186/1471-2180-7-102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Losick VP, Isberg RR. NF-kappaB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J Exp Med. (2006) 203:2177–89. 10.1084/jem.20060766 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Abu-Zant A, Jones S, Asare R, Suttles J, Price C, Graham J, et al. Anti-apoptotic signalling by the Dot/Icm secretion system of L. pneumophila. Cell Microbiol. (2007) 9:246–64. 10.1111/j.1462-5822.2006.00785.x [DOI] [PubMed] [Google Scholar]
- 70.Brandt S, Kwok T, Hartig R, König W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA. (2005) 102:9300–5. 10.1073/pnas.0409873102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Carneiro LA, Travassos LH, Soares F, Tattoli I, Magalhaes JG, Bozza MT, et al. Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells. Cell Host Microbe (2009) 5:123–36. 10.1016/j.chom.2008.12.011 [DOI] [PubMed] [Google Scholar]
- 72.Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 312:1211–4. 10.1126/science.1126867 [DOI] [PubMed] [Google Scholar]
- 73.Loeuillet C, Martinon F, Perez C, Munoz M, Thome M, Meylan PR. Mycobacterium tuberculosis subverts innate immunity to evade specific effectors. J Immunol. (2006) 177:6245–55. 10.4049/jimmunol.177.9.6245 [DOI] [PubMed] [Google Scholar]
- 74.Nelson G, Paraoan L, Spiller DG, Wilde GJ, Browne MA, Djali PK, et al. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells. J Cell Sci. (2002) 115:1137–48. [DOI] [PubMed] [Google Scholar]
- 75.Horton CA, See V, Johnson JR, Nelson G, Spiller DG, Kell DB, et al. Response to comment on “Oscillations in NF-κB signaling control the dynamics of gene expression”. Science (2005) 308:52 10.1126/science.110790415802586 [DOI] [Google Scholar]